Treatment of CCR2 mediated diseases or disorders

Details for Australian Patent Application No. 2005268545 (hide)

Owner Pfizer Products Inc.

Inventors Cornelius, Peter; Garofalo, Robert Sebastian; Gladue, Ronald Paul

Agent Allens Arthur Robinson

Pub. Number AU-A-2005268545

PCT Pub. Number WO2006/013427

Priority 60/592,683 30.07.04 US

Filing date 18 July 2005

Wipo publication date 9 February 2006

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/013427 Priority application(s): WO2006/013427

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268547-System and method for informing a sender of content adaptation and message failure issues

2005268540-Pipe coupling